RudaCure Co.
Latest round
- Series A
Last raised
- May 2023
Total raised
- $5.1M
Investors
- 4
About RudaCure Co.
, Ltd is a biotechnology company that develops a treatment for dry eye syndrome and treatment for chronic pain., Ltd develops ophthalmic diseases such as dry eye syndrome and age-related macular degeneration as well as provides treatment for neuropathic pain and cancer pain. It offers RCI001 for dry eye treatment, RCI002 for pain treatment, and RCI005 for macular degeneration treatment. In addition, the company also provides animal model development for pain and ophthalmic disease, electrophysiological research, and drug toxicity and evaluation services.
Who invested in RudaCure Co.
4 investors across 3 rounds
See all investors in RudaCure Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RudaCure Co.
Who invested in RudaCure Co.?
RudaCure Co. has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RudaCure Co. raised?
RudaCure Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did RudaCure Co. last raise money?
RudaCure Co.'s most recent round on record is a Series A, in May 2023.
What does RudaCure Co. do?
, Ltd is a biotechnology company that develops a treatment for dry eye syndrome and treatment for chronic pain.
Where is RudaCure Co. headquartered?
RudaCure Co. is headquartered in Incheon, South Korea.
Which VCs invest in companies like RudaCure Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at RudaCure Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like RudaCure Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.